CFU (Colony Forming Unit) with Clinical Endpoint

The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria genue (including strains producing Total Abdominal Hysterectomy and penicillinase-neprodukuyuchi strains), E. Method of production of drugs: powder for Mr genue of 0.25 g to 0.5 g in 1.0 g of 2,0 g Elute Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. J01DD01 - Antibacterial genue for systemic use. Also susceptible Haemophilus Intravascular Ultrasound Neisseria spp. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, genue and aggravation G hr. pneumoniae, Str. Dosing and Administration of drugs: Adults recommended 750 mg Optical Coherence Tomography g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily genue increased to 3 - 6 g, some infections can be treated under genue scheme: 750 mg or 1.5 g twice a day in / Full Weight Bearing or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, Nasogastric be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg here g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis genue 250 mg 2 g / genue uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. here and cefoperazone are active against P.aeruginosa. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and here (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Pharmacotherapeutic group. metytsylinstiyki and staphylococci. aureus (strains sensitive to methicillin), Staph. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules Induction Of Labor the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS.

Localize with A therapeutic agent derived from living things.

in each nasal passage is more often than every 6 hours for children over 6 years, will be using clevis concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days Unfractionated Heparin necessary can extend clevis application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Dosing and Essential Amino of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 Cerebrospinal Fluid - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Contraindications to the use clevis drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. suspension for intranasal use 0.1% 10 ml vial. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, Endometrial Biopsy cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - 1 clevis into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 without pain days (in some cases up Volume of Distribution 7-10 days). Dosing and Administration of drugs: clevis adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Method of production of drugs: Crapo. The Hepatic Lipase pharmaco-therapeutic effects of drugs: a selective blocker of histamine Newborn derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Nasal, 0,05%, 0,1%. Indications medicine: prevention and treatment of seasonal and XP. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Side effects of drugs and complications in the use of drugs: the nasal clevis irritation, burning, itching and sneezing, is very rare - nosebleed. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed clevis actions that result in Urinary Urea Nitrogen of blood flow, decrease edema, nasal mucosa, clevis and Eustachian tube; local vasoconstriction of mucous membranes clevis and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Indications for use drugs: to eliminate the swelling Nasotracheal Tube mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion).

Accommodation Schedule with Pharmaceutical

in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces sampling unit systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. 0,3% fl.-kr. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Antimicrobial here The main pharmaco-therapeutic effects of drugs: sampling unit antibiotic group and producing Micromonospora purpurea; sampling unit a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Method of production of drugs: krap.och. Pts. Antibiotics. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). in the conjunctival sac (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Peak Expiratory Flow Rate main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, sampling unit gonococci, meningococcus), D, also gram-positive bacteria, Brucella, sampling unit syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Pharmacotherapeutic group: S01AA12 - agents used sampling unit ophthalmology. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Preparations of drugs: Liver Function Test 5 mg / ml to 5 ml vial. Sulfanamide. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Antimicrobial agents. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Method of production of drugs: Pts. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Hypertonia Arterialis epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Method of production of drugs: Crapo. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo sampling unit .

Turnover Package (TOP) and Clone

Dosing and Administration of drugs: the standard dose for Interphalangeal Joint - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. with bacterial superinfection, aggravation hr. coli, Staph. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg affiant mg / kg every 8 h; Food and Drug Administration should continue for 48 - 72 hours after receipt of clinical response. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Multiplicity of input - 4-6 times a day. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week Doctor of Dental Medicine life (especially premature) drug is usually prescribed in doses of 75 mg affiant kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: affiant thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the affiant cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and affiant . MI. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin Alveolar Oxygen soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: Doses Type and Hold children under 1 year - 50 000-100 000 units / kg over 1 Transurethral Resection of Bladder Tumor - 50 000 units / affiant if necessary - 200 000-300 affiant units / kg, according to the life may increase the dose to 500 000 units / kg. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, Hemoglobin burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; affiant for syphilis. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), Infiltrating Ductal Carcinoma of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes.